Skip to main content
. 2022 Dec 26;11:112. doi: 10.4103/abr.abr_203_21

Table 3.

Comparison of coronavirus disease 2019 infection prevalence in different stages of chronic kidney disease

Stages of CKD No infection to COVID-19 (n=390), n (%) Infection to COVID-19 (n=13), n (%) P
CKD stage 1 A1 73 (18.7) 4 (30.9) 0.894
CKD stage 1 A2 69 (17.7) 1 (7.6)
CKD stage 1 A3 7 (1.8) 0
CKD stage 2 A1 72 (18.5) 4 (30.9)
CKD stage 2 A2 85 (21.8) 0
CKD stage 2 A3 4 (1) 1 (7.6)
CKD stage 3a A1 47 (12.1) 2 (15.4)
CKD stage 3a A2 12 (3.1) 1 (7.6)
CKD stage 3a A3 1 (0.2) 0
CKD stage 3b A1 6 (1.5) 0
CKD stage 3b A2 7 (1.8) 0
CKD stage 4 A1 1 (0.3) 0
CKD stage 4 A3 6 (1.5) 0

P<0.05 was considered statistically significant. CKD: Chronic kidney disease, COVID-19: Coronavirus disease 2019